Literature DB >> 15184389

Group I metabotropic glutamate receptors mediate a dual role of glutamate in T cell activation.

Rodrigo Pacheco1, Francisco Ciruela, Vicent Casadó, Josefa Mallol, Teresa Gallart, Carmen Lluis, Rafael Franco.   

Abstract

Metabotropic glutamate receptors (mGluR) are present in cells of the nervous system, where they are activated by one of the main neurotransmitters, glutamate. They are also expressed in cells outside the nervous system. We identified and characterized two receptors belonging to group I mGluR, mGlu1R and mGlu5R, in human cell lines of lymphoid origin and in resting and activated lymphocytes from human peripheral blood. Both are highly expressed in the human Jurkat T cell line, whereas mGlu5R is expressed only in the human B cell line SKW6.4. In blood lymphocytes, mGlu5R is expressed constitutively, whereas mGlu1R is expressed only upon activation via the T cell receptor-CD3 complex. Group I receptors in the central nervous system are coupled to phospholipase C, whereas in blood lymphocytes, activation of mGlu5R does not trigger this signaling pathway, but instead activates adenylate cyclase. On the other hand, mGlu5R does not mediate ERK1/2 activation, whereas mGlu1R, which is coupled neither to phospholipase C nor to calcium channels and whose activation does not increase cAMP, activates the mitogen-activated protein kinase cascade. The differential expression of mGluR in resting and activated lymphocytes and the different signaling pathways that are triggered when mGlu1Rs or mGlu5Rs are activated point to a key role of glutamate in the regulation of T cell physiological function. The study of the signaling pathways (cAMP production and ERK1/2 phosphorylation) and the proliferative response obtained in the presence of glutamate analogs suggests that mGlu1R and mGlu5R have distinct functions. mGlu5R mediates the reported inhibition of cell proliferation evoked by glutamate, which is reverted by the activation of inducible mGlu1R. This is a novel non-inhibitory action mechanism for glutamate in lymphocyte activation. mGlu1R and mGlu5R thus mediate opposite glutamate effects in human lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184389     DOI: 10.1074/jbc.M401761200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Immune dysfunction in autism: a pathway to treatment.

Authors:  Milo Careaga; Judy Van de Water; Paul Ashwood
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

2.  Sustained calcium signalling and caspase-3 activation involve NMDA receptors in thymocytes in contact with dendritic cells.

Authors:  P Affaticati; O Mignen; F Jambou; M-C Potier; I Klingel-Schmitt; J Degrouard; S Peineau; E Gouadon; G L Collingridge; R Liblau; T Capiod; S Cohen-Kaminsky
Journal:  Cell Death Differ       Date:  2010-06-25       Impact factor: 15.828

3.  Albuminuria and glomerular damage in mice lacking the metabotropic glutamate receptor 1.

Authors:  Aldamaria Puliti; Pia Irene Anna Rossi; Gianluca Caridi; Alessandro Corbelli; Masami Ikehata; Silvia Armelloni; Min Li; Cristina Zennaro; Valerio Conti; Carlotta Maria Vaccari; Michela Cassanello; Maria Grazia Calevo; Laura Emionite; Roberto Ravazzolo; Maria Pia Rastaldi
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

Review 4.  The role of glutamate in neuronal ischemic injury: the role of spark in fire.

Authors:  Botros B Kostandy
Journal:  Neurol Sci       Date:  2011-11-02       Impact factor: 3.307

Review 5.  The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells.

Authors:  Yonatan Ganor; Mia Levite
Journal:  J Neural Transm (Vienna)       Date:  2014-03-02       Impact factor: 3.575

6.  Metabotropic glutamate receptor 5 activation inhibits microglial associated inflammation and neurotoxicity.

Authors:  Kimberly R Byrnes; Bogdan Stoica; David J Loane; Angela Riccio; Margaret I Davis; Alan I Faden
Journal:  Glia       Date:  2009-04-01       Impact factor: 7.452

Review 7.  Fragile X Syndrome and Alzheimer's Disease: Another story about APP and beta-amyloid.

Authors:  J S Malter; B C Ray; P R Westmark; C J Westmark
Journal:  Curr Alzheimer Res       Date:  2010-05       Impact factor: 3.498

8.  Autosomal-recessive congenital cerebellar ataxia is caused by mutations in metabotropic glutamate receptor 1.

Authors:  Velina Guergueltcheva; Dimitar N Azmanov; Dora Angelicheva; Katherine R Smith; Teodora Chamova; Laura Florez; Michael Bynevelt; Thai Nguyen; Sylvia Cherninkova; Veneta Bojinova; Ara Kaprelyan; Lyudmila Angelova; Bharti Morar; David Chandler; Radka Kaneva; Melanie Bahlo; Ivailo Tournev; Luba Kalaydjieva
Journal:  Am J Hum Genet       Date:  2012-08-16       Impact factor: 11.025

9.  Transcriptional profiling of the rat frontal cortex following administration of the mGlu5 receptor antagonists MPEP and MTEP.

Authors:  Justin T Gass; M Foster Olive
Journal:  Eur J Pharmacol       Date:  2008-02-20       Impact factor: 4.432

Review 10.  The cyclic AMP phenotype of fragile X and autism.

Authors:  Daniel J Kelley; Anita Bhattacharyya; Garet P Lahvis; Jerry C P Yin; Jim Malter; Richard J Davidson
Journal:  Neurosci Biobehav Rev       Date:  2008-06-17       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.